SIX •
Healthcare •
Biotechnology •
Quote as of 09/11/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization2,967.03 mln
Earnings Date10/23/2026
EPS
24.57
Exceptional
P / E
2.14
Deeply undervalued
Piotroski F-Score
5
/ 9
Neutral
Relative Strength
6
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
Pre-Tax Margin
98%
Exceptional margin
Business Description
Founded in Switzerland in 1993, BB Biotech AG is an investment fund run by Bellevue Asset Management AG. The fund buys shares in publicly traded companies around the world that develop medicines and diagnostic tools using biotechnology. Investment decisions are guided by in-depth research into each company's underlying business fundamentals.
